Wells Fargo has recently initiated Exact Sciences Corp (EXAS) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on June 27, 2024, Scotiabank had initiated the ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Hosted on MSN24d
Wells Fargo Initiates Coverage of Exact Sciences (EXAS) with Overweight RecommendationAnalyst Price Forecast Suggests 28.14% Upside As of August 26, 2024, the average one-year price target for Exact Sciences is $78.36/share. The forecasts range from a low of $60.60 to a high of ...
MADISON, Wis., August 28, 2024--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback